secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-07-08T23:59:59+00:00
Accession:  0001213900-25-061911
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics regains Nasdaq bid price compliance; delisting hearing canceled
--------------------------------------------------------------------------------

- On July 7, 2025, Nasdaq determined CERo regained compliance with the $1.00 minimum bid price rule.
- Company had received a deficiency notice on June 11, 2025, for 30 consecutive days of sub-$1.00 closing bid.
- CERo timely appealed the delisting determination and requested a hearing, which stayed the suspension.
- Nasdaq canceled the scheduled hearing because compliance was restored; common stock continues on Nasdaq Capital Market.
- Tickers CERO (common) and CEROW (warrants) remain listed on the Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025061911/0001213900-25-061911-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025061911/ea0248316-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-061911

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer